Personalised Health Recommendations to the General Population Through an Integrated AI Guided

Launched by FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL CLÍNICO DE VALENCIA · May 17, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to improve health recommendations for people at risk of gastric cancer and related conditions by using an advanced tool called AIDA. The study has two phases: the first phase focuses on identifying people's risk levels and creating personalized health recommendations based on that information. The second phase will involve developing and testing a model to better understand the factors that contribute to these conditions.

To participate in the trial, you need to be at least 18 years old and have either a diagnosis of a specific stomach condition or a history of infection with Helicobacter pylori, which is a common bacteria linked to stomach issues. If you are eligible, you will be asked to sign a consent form and may undergo a procedure called gastroscopy, which allows doctors to look at your stomach. It's important to note that certain people, like those undergoing other treatments or those who have used specific medications recently, may not qualify for the study. If you decide to participate, you'll be contributing to research that aims to improve prevention and treatment strategies for gastric cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects ≥ 18 years old with a diagnosis of GIM or previous or current H. pylori infection, to whom a gastroscopy is indicated within clinical care
• • Availability of a signed informed consent form to participate in the study
• Exclusion Criteria:
• • Patients to whom an endoscopy is performed for the follow-up of another illness such as oesophageal varices and/or for therapy such as endoscopic dilation, feeding tube placement or endoscopic resection
• • Subjects with a clinical diagnosis of gastric diseases other than GIM or GC
• • Patients who have received antimicrobials during the four weeks prior to the endoscopy
• • Patients who have received proton pump inhibitors and/or bismuth-based treatments at least two weeks prior to the endoscopy
• • Subjects for whom clinical data are not available: H. pylori status, eradication treatment, sex, age, tobacco smoking, and first-degree family history of gastric cancer
• • Subjects who lack the mental capacity to understand the nature and requirements of the study and who lack the ability to give informed consent

Trial Officials